People familiar with the matter said that China plans to approve its first foreign Covid-19 vaccine by July because of increasing pressure from domestic scientists and foreign businesses to expand its gun list.
People familiar with the matter said that Chinese officials have been reviewing clinical trial data of the coronavirus vaccine produced by Germany’s BioNTech SE and are expected to approve the domestic release of the vaccine within the next 10 weeks. In private discussions with the government and health officials, some people were informed of the timetable. Others briefed government officials on internal discussions.
The test data cited by most injection manufacturers in China show that their vaccine is effective in preventing Covid-1
According to Ker Gibbs, president of the American Chamber of Commerce in Shanghai, foreign companies are eager to increase Western vaccines to make it easier to travel abroad because foreigners are more accepting of such vaccinations. He said the Chamber of Commerce has been urging the government to approve the BioNTech vaccine, which has been produced and distributed by Pfizer in most parts of the world since December.
BioNTech agreed to cooperate with Shanghai Fosun Pharmaceutical Group Co., Ltd. in December, and will provide 100 million doses to China in 2021, pending approval.